Show simple item record

dc.contributor.authorPollock, K
dc.contributor.authorRanes, M
dc.contributor.authorCollins, I
dc.contributor.authorGuettler, S
dc.date.accessioned2017-08-23T09:07:29Z
dc.date.issued2017-01-01
dc.identifier.citationMethods in molecular biology (Clifton, N.J.), 2017, 1608 pp. 445 - 473
dc.identifier.issn1064-3745
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/790
dc.identifier.eissn1940-6029
dc.identifier.doi10.1007/978-1-4939-6993-7_28
dc.description.abstractThe poly(ADP-ribose)polymerase (PARP) enzyme tankyrase (TNKS/ARTD5, TNKS2/ARTD6) uses its ankyrin repeat clusters (ARCs) to recognize degenerate peptide motifs in a wide range of proteins, thereby recruiting such proteins and their complexes for scaffolding and/or poly(ADP-ribosyl)ation. Here, we provide guidance for predicting putative tankyrase-binding motifs, based on the previously delineated peptide sequence rules and existing structural information. We present a general method for the expression and purification of tankyrase ARCs from Escherichia coli and outline a fluorescence polarization assay to quantitatively assess direct ARC-TBM peptide interactions. We provide a basic protocol for evaluating binding and poly(ADP-ribosyl)ation of full-length candidate interacting proteins by full-length tankyrase in mammalian cells.
dc.formatPrint
dc.format.extent445 - 473
dc.languageeng
dc.language.isoeng
dc.publisherSpringer New York
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectTelomere
dc.subjectAnimals
dc.subjectHumans
dc.subjectTankyrases
dc.subjectBinding Sites
dc.subjectProtein Binding
dc.subjectPoly ADP Ribosylation
dc.titleIdentifying and Validating Tankyrase Binders and Substrates: A Candidate Approach.
dc.typeJournal Article
dcterms.dateAccepted2017-01-01
rioxxterms.versionofrecord10.1007/978-1-4939-6993-7_28
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfMethods in molecular biology (Clifton, N.J.)
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 2
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology/Structural Biology of Cell Signalling
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 2
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology/Structural Biology of Cell Signalling
pubs.publication-statusPublished
pubs.volume1608
pubs.embargo.termsNo embargo
icr.researchteamMedicinal Chemistry 2
icr.researchteamStructural Biology of Cell Signalling
dc.contributor.icrauthorPollock, Katie
dc.contributor.icrauthorCollins, Ian
dc.contributor.icrauthorGuettler, Sebastian


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0